APA (7th ed.) Citation

Jordan, P., McCall, R., Patel, A., Owen, D. H., Amini, A., Liu, A., . . . Aerts, H. (2023). Multi-center real-world data curation and assessment of tumor growth rate and overall survival in advanced NSCLC treated with PD-(L)1 immune checkpoint inhibitor therapy. Journal of clinical oncology, 41(16_suppl), 9124. https://doi.org/10.1200/JCO.2023.41.16_suppl.9124

Chicago Style (17th ed.) Citation

Jordan, Petr, et al. "Multi-center Real-world Data Curation and Assessment of Tumor Growth Rate and Overall Survival in Advanced NSCLC Treated with PD-(L)1 Immune Checkpoint Inhibitor Therapy." Journal of Clinical Oncology 41, no. 16_suppl (2023): 9124. https://doi.org/10.1200/JCO.2023.41.16_suppl.9124.

MLA (9th ed.) Citation

Jordan, Petr, et al. "Multi-center Real-world Data Curation and Assessment of Tumor Growth Rate and Overall Survival in Advanced NSCLC Treated with PD-(L)1 Immune Checkpoint Inhibitor Therapy." Journal of Clinical Oncology, vol. 41, no. 16_suppl, 2023, p. 9124, https://doi.org/10.1200/JCO.2023.41.16_suppl.9124.